Accessibility: Skip TopNav
Figure 3A, 3B
Percent Reduction in Mean EASI for Cohorts 1-4– Breakout of Patients with or without Prior Systemic Therapy.
Format
PNG
Quelle:
Corvus Pharmaceuticals, Inc.
Downloads
Originalgröße
Groß
Mittel
Klein